Skip to main content

Table 2 % Ratio of untransformed data (Artefan® to Coartem ® ) and a comparison of data obtained by Norvatis

From: Comparison of bioavailability between the most available generic tablet formulation containing artemether and lumefantrine on the Tanzanian market and the innovator’s product

Primary Parameter

Artefan ®

Coartem ®

P value

% Ratio of test to reference

Norvatis Data on file (Riamet)

Arithmetic mean ± SD

Arithmetic mean ± SD

  

Arithmetic mean

(*)

(*)

   

Tmax (h)

6.11±2.698

6.2±2.2

0.8950

-

6 – 8

Cmax (ng/ml)

4206.9±2942.5 (3144.0)

4438.81±2548.432 (3742.267)

0.7836

84.0

5100-9800

AUC0-168 (ng.h/ml)

123758.9±83527.5 (93175.97)

135430.7±86814.8 (109729.0)

0.6612

84.5

-

AUC0-∞ (ng.h/ml)

138189.7±94959.8 (102441.5)

149530.2±95109.4 (121576.3)

0.7022

84.3

108000- 243000

  1. *Geometric mean.